GSK research — incidence of pertussis among U.S. adults 50 and older may be greatly under-reported and under-recognized

GSK research released at the 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) reported that “the incidence of pertussis among U.S. adults 50 and older may be greatly under-reported and under-recognized.”  The research estimated that the actual number of pertussis cases was approximately 520,000 versus the 8,764 medically-attended cases among U.S. adults ages 50 to 64, and approximately 465,000 versus 6,359 medically-attended pertussis cases among adults 65 and older in the same database. That equates to an incidence on average of 202 per 100,000 in adults 50-64, and 257 per 100,000 among adults 65 and older. These estimated incidences were about 42 to 105 times higher than the medically-attended pertussis cases documented in the same database during the years 2006-2010. In 2010, the estimated incidence was 94 and 264 times higher than nationally reported incidences for individuals aged 50-64 and 65 and older, respectively. The GSK researchers who led the study, Cristina Masseria, Ph.D, and Girishanthy Krishnarajah, MPH, MBA/MS, utilized data from the IMS private practice database that included more than 80 million claims per year and analyzed approximately 48 million cases of cough-related illness in the U.S. between 2006 and 2010. The commercial laboratory testing database represents approximately 40 percent of respiratory-laboratory testing that took place in the U.S. during the years looked at in the study.

Leonard Friedland, M.D., Vice President and Director of Scientific Affairs and Public Health for GSK Vaccines, noted, “The CDC, other public health authorities and infectious disease experts have long suspected that pertussis cases in adults go undetected or are misdiagnosed as other respiratory ailments . To our knowledge, this is the first attempt to quantify the incidence of cough illness attributed to B. pertussis via regression modeling among those greater than 50 years old. The authors plan to share their research methods and welcome other researchers to further examine and build upon the findings of this study. These findings suggest a major need for healthcare providers to consider the possibility of pertussis in older patients they see who have respiratory symptoms.”

Full media release: http://www.prnewswire.com/news-releases/gsk-research-estimates-significantly-higher-rates-of-pertussis-among-older-adults-than-now-reported-223473661.html